OCULAR SURFACE SQUAMOUS NEOPLASIA

This adverse event was reported 25 times

These drugs are most commonly taken by patients reporting OCULAR SURFACE SQUAMOUS NEOPLASIA:

# Drug Count
0 VORICONAZOLE 8
1 VORICONAZOLE INJECTION 8
2 PREDNISONE 7
3 DOXYCYCLINE 6
4 DOXYCYCLINE HYCLATE 6
5 RANITIDINE 6
6 ITRACONAZOLE 5
7 VITAMIN C 4
8 ASCORBIC ACID 2
9 CERTOLIZUMAB PEGOL 2
See all common drugs associated with OCULAR SURFACE SQUAMOUS NEOPLASIA

OCULAR SURFACE SQUAMOUS NEOPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NATAMYCIN 2 0.0049
1 AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) 1 0.0033
2 ITRACONAZOLE 5 0.0004
3 DEFLAZACORT 1 0.0004
4 VORICONAZOLE 8 0.0003
5 GLUCAGON 1 0.0002
6 CILTACABTAGENE AUTOLEUCEL 1 0.0002
7 CEFTAZIDIME 1 0.0001
8 TRAVOPROST 1 0.0001
9 TESTOSTERONE CYPIONATE 1 0.0001
See all drugs enriched for association with OCULAR SURFACE SQUAMOUS NEOPLASIA

OCULAR SURFACE SQUAMOUS NEOPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Polyene Antimicrobial [EPC] 2 0.0049
1 Endoglycosidase [EPC] 1 0.0005
2 Antihypoglycemic Agent [EPC] 1 0.0002
3 Tetracycline-class Drug [EPC] 6 0.0001
4 Azole Antifungal [EPC] 8 0.0001
5 Oxazolidinone Antibacterial [EPC] 1 0.0000
6 Vitamin C [EPC] 7 0.0000
7 Central Nervous System Stimulant [EPC] 1 0.0000
8 Nitrate Vasodilator [EPC] 1 0.0000
9 Prostaglandin Analog [EPC] 1 0.0000
See all drug classes enriched for association with OCULAR SURFACE SQUAMOUS NEOPLASIA